4AP for Carpal Tunnel Syndrome (CTS)

Summary

The investigators have found recent promising data supporting the use of a currently FDA approved drug, 4-aminopyridine, in the treatment of nerve injury including compression neuropathy. The purpose of this research is determine whether 4-aminopyridine can treat carpal tunnel syndrome or delay the need for formal surgical release in patients with known carpal tunnel syndrome who would otherwise undergo surgery.

Timeline

Start

2026-11

Primary completion

2027-12

Completion

2028-07

Drugs

Indications